1509 related articles for article (PubMed ID: 32301997)
1. Detectable Serum Severe Acute Respiratory Syndrome Coronavirus 2 Viral Load (RNAemia) Is Closely Correlated With Drastically Elevated Interleukin 6 Level in Critically Ill Patients With Coronavirus Disease 2019.
Chen X; Zhao B; Qu Y; Chen Y; Xiong J; Feng Y; Men D; Huang Q; Liu Y; Yang B; Ding J; Li F
Clin Infect Dis; 2020 Nov; 71(8):1937-1942. PubMed ID: 32301997
[TBL] [Abstract][Full Text] [Related]
2. Viral RNA load in plasma is associated with critical illness and a dysregulated host response in COVID-19.
Bermejo-Martin JF; González-Rivera M; Almansa R; Micheloud D; Tedim AP; Domínguez-Gil M; Resino S; Martín-Fernández M; Ryan Murua P; Pérez-García F; Tamayo L; Lopez-Izquierdo R; Bustamante E; Aldecoa C; Gómez JM; Rico-Feijoo J; Orduña A; Méndez R; Fernández Natal I; Megías G; González-Estecha M; Carriedo D; Doncel C; Jorge N; Ortega A; de la Fuente A; Del Campo F; Fernández-Ratero JA; Trapiello W; González-Jiménez P; Ruiz G; Kelvin AA; Ostadgavahi AT; Oneizat R; Ruiz LM; Miguéns I; Gargallo E; Muñoz I; Pelegrin S; Martín S; García Olivares P; Cedeño JA; Ruiz Albi T; Puertas C; Berezo JÁ; Renedo G; Herrán R; Bustamante-Munguira J; Enríquez P; Cicuendez R; Blanco J; Abadia J; Gómez Barquero J; Mamolar N; Blanca-López N; Valdivia LJ; Fernández Caso B; Mantecón MÁ; Motos A; Fernandez-Barat L; Ferrer R; Barbé F; Torres A; Menéndez R; Eiros JM; Kelvin DJ
Crit Care; 2020 Dec; 24(1):691. PubMed ID: 33317616
[TBL] [Abstract][Full Text] [Related]
3. RNAemia Corresponds to Disease Severity and Antibody Response in Hospitalized COVID-19 Patients.
Eberhardt KA; Meyer-Schwickerath C; Heger E; Knops E; Lehmann C; Rybniker J; Schommers P; Eichenauer DA; Kurth F; Ramharter M; Kaiser R; Holtick U; Klein F; Jung N; Di Cristanziano V
Viruses; 2020 Sep; 12(9):. PubMed ID: 32962125
[TBL] [Abstract][Full Text] [Related]
4. Kinetics of viral load and antibody response in relation to COVID-19 severity.
Wang Y; Zhang L; Sang L; Ye F; Ruan S; Zhong B; Song T; Alshukairi AN; Chen R; Zhang Z; Gan M; Zhu A; Huang Y; Luo L; Mok CKP; Al Gethamy MM; Tan H; Li Z; Huang X; Li F; Sun J; Zhang Y; Wen L; Li Y; Chen Z; Zhuang Z; Zhuo J; Chen C; Kuang L; Wang J; Lv H; Jiang Y; Li M; Lin Y; Deng Y; Tang L; Liang J; Huang J; Perlman S; Zhong N; Zhao J; Malik Peiris JS; Li Y; Zhao J
J Clin Invest; 2020 Oct; 130(10):5235-5244. PubMed ID: 32634129
[TBL] [Abstract][Full Text] [Related]
5. Profiling serum cytokines in COVID-19 patients reveals IL-6 and IL-10 are disease severity predictors.
Han H; Ma Q; Li C; Liu R; Zhao L; Wang W; Zhang P; Liu X; Gao G; Liu F; Jiang Y; Cheng X; Zhu C; Xia Y
Emerg Microbes Infect; 2020 Dec; 9(1):1123-1130. PubMed ID: 32475230
[TBL] [Abstract][Full Text] [Related]
6. Longitudinal correlation of biomarkers of cardiac injury, inflammation, and coagulation to outcome in hospitalized COVID-19 patients.
Li C; Jiang J; Wang F; Zhou N; Veronese G; Moslehi JJ; Ammirati E; Wang DW
J Mol Cell Cardiol; 2020 Oct; 147():74-87. PubMed ID: 32827510
[TBL] [Abstract][Full Text] [Related]
7. Pro- and Anti-Inflammatory Responses in Severe COVID-19-Induced Acute Respiratory Distress Syndrome-An Observational Pilot Study.
Notz Q; Schmalzing M; Wedekink F; Schlesinger T; Gernert M; Herrmann J; Sorger L; Weismann D; Schmid B; Sitter M; Schlegel N; Kranke P; Wischhusen J; Meybohm P; Lotz C
Front Immunol; 2020; 11():581338. PubMed ID: 33123167
[TBL] [Abstract][Full Text] [Related]
8. Characteristics and prognostic factors of disease severity in patients with COVID-19: The Beijing experience.
Sun Y; Dong Y; Wang L; Xie H; Li B; Chang C; Wang FS
J Autoimmun; 2020 Aug; 112():102473. PubMed ID: 32439209
[TBL] [Abstract][Full Text] [Related]
9. Viral load dynamics and disease severity in patients infected with SARS-CoV-2 in Zhejiang province, China, January-March 2020: retrospective cohort study.
Zheng S; Fan J; Yu F; Feng B; Lou B; Zou Q; Xie G; Lin S; Wang R; Yang X; Chen W; Wang Q; Zhang D; Liu Y; Gong R; Ma Z; Lu S; Xiao Y; Gu Y; Zhang J; Yao H; Xu K; Lu X; Wei G; Zhou J; Fang Q; Cai H; Qiu Y; Sheng J; Chen Y; Liang T
BMJ; 2020 Apr; 369():m1443. PubMed ID: 32317267
[TBL] [Abstract][Full Text] [Related]
10. Serum Cytokine and Chemokine Profile in Relation to the Severity of Coronavirus Disease 2019 in China.
Chi Y; Ge Y; Wu B; Zhang W; Wu T; Wen T; Liu J; Guo X; Huang C; Jiao Y; Zhu F; Zhu B; Cui L
J Infect Dis; 2020 Aug; 222(5):746-754. PubMed ID: 32563194
[TBL] [Abstract][Full Text] [Related]
11. Highly Sensitive Quantification of Plasma Severe Acute Respiratory Syndrome Coronavirus 2 RNA Sheds Light on its Potential Clinical Value.
Veyer D; Kernéis S; Poulet G; Wack M; Robillard N; Taly V; L'Honneur AS; Rozenberg F; Laurent-Puig P; Bélec L; Hadjadj J; Terrier B; Péré H
Clin Infect Dis; 2021 Nov; 73(9):e2890-e2897. PubMed ID: 32803231
[TBL] [Abstract][Full Text] [Related]
12. IP-10 and MCP-1 as biomarkers associated with disease severity of COVID-19.
Chen Y; Wang J; Liu C; Su L; Zhang D; Fan J; Yang Y; Xiao M; Xie J; Xu Y; Li Y; Zhang S
Mol Med; 2020 Oct; 26(1):97. PubMed ID: 33121429
[TBL] [Abstract][Full Text] [Related]
13. Tocilizumab treatment in COVID-19: A single center experience.
Luo P; Liu Y; Qiu L; Liu X; Liu D; Li J
J Med Virol; 2020 Jul; 92(7):814-818. PubMed ID: 32253759
[TBL] [Abstract][Full Text] [Related]
14. Clinical Characteristics of Patients with Severe Pneumonia Caused by the SARS-CoV-2 in Wuhan, China.
Wang Y; Zhou Y; Yang Z; Xia D; Hu Y; Geng S
Respiration; 2020; 99(8):649-657. PubMed ID: 32841948
[TBL] [Abstract][Full Text] [Related]
15. Relationship Between Serum Severe Acute Respiratory Syndrome Coronavirus 2 Nucleic Acid and Organ Damage in Coronavirus 2019 Patients: A Cohort Study.
Xu D; Zhou F; Sun W; Chen L; Lan L; Li H; Xiao F; Li Y; Kolachalama VB; Li Y; Wang X; Xu H
Clin Infect Dis; 2021 Jul; 73(1):68-75. PubMed ID: 32720678
[TBL] [Abstract][Full Text] [Related]
16. Clinical Characteristics and Immune Injury Mechanisms in 71 Patients with COVID-19.
Wu Y; Huang X; Sun J; Xie T; Lei Y; Muhammad J; Li X; Zeng X; Zhou F; Qin H; Shao L; Zhang Q
mSphere; 2020 Jul; 5(4):. PubMed ID: 32669467
[TBL] [Abstract][Full Text] [Related]
17. Using IL-2R/lymphocytes for predicting the clinical progression of patients with COVID-19.
Hou H; Zhang B; Huang H; Luo Y; Wu S; Tang G; Liu W; Mao L; Mao L; Wang F; Sun Z
Clin Exp Immunol; 2020 Jul; 201(1):76-84. PubMed ID: 32365221
[TBL] [Abstract][Full Text] [Related]
18. Interleukin-6 as a potential biomarker of COVID-19 progression.
Ulhaq ZS; Soraya GV
Med Mal Infect; 2020 Jun; 50(4):382-383. PubMed ID: 32259560
[No Abstract] [Full Text] [Related]
19. Association between cytokine profiles and lung injury in COVID-19 pneumonia.
Chen LD; Zhang ZY; Wei XJ; Cai YQ; Yao WZ; Wang MH; Huang QF; Zhang XB
Respir Res; 2020 Jul; 21(1):201. PubMed ID: 32727465
[TBL] [Abstract][Full Text] [Related]
20. Prognostic value of interleukin-6, C-reactive protein, and procalcitonin in patients with COVID-19.
Liu F; Li L; Xu M; Wu J; Luo D; Zhu Y; Li B; Song X; Zhou X
J Clin Virol; 2020 Jun; 127():104370. PubMed ID: 32344321
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
